Status:
COMPLETED
In-person vs. Remote Wellness Support
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Depressive Disorder, Major
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study team will use components of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to compare Cognitive Adaptation Training (CAT) to Remotely delivered Cognitive ...
Detailed Description
Individuals choosing or assigned to R-CAT will continue treatment as usual with their health care team and R-CAT will be added. R-CAT is a remotely delivered version of CAT focused on medication adher...
Eligibility Criteria
Inclusion
- Able to give informed consent.
- Between the ages of 18 and 65.
- Clinical Diagnosis of Major Depressive Disorder, Bipolar disorder, Schizophrenia, or Schizoaffective Disorder
- Receiving treatment with oral psychiatric medications.
- Have had a hospitalization or emergency department visit in the past year
- Have a Medication Possession Ratio (MPR) based upon electronic refill data below 80% at least 1 of the past 4 quarters with at least 1 psychiatric medication
- Responsible for taking their own medications
- Report on telephone prescreen call with researcher team that they have missed at least 2 doses of medication in the past 3 weeks, that they are willing to take medication and would like remote assistance to take medication more regularly
- Report on telephone prescreen call with research team that they have a stable living environment (individual apartment, family home, board and care facility) within the last three months and no plans to move in the next year
- Report on prescreen research call with research team that they have no plans to change their MCO in the next 12 months
- Have a working smart phone
- Able to understand and complete rating scales and assessments.
- Agree to home visits for intervention and to count pills and conduct assessments
Exclusion
- Substance dependence within the past 2 months
- Currently being treated by an ACT team
- Documented history of violence or threatening behavior on initial assessment
- Receive home visits to assist with medication adherence
- Unable to complete baseline assessments
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04526067
Start Date
November 24 2020
End Date
November 11 2022
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center - Department of Psychiatry
San Antonio, Texas, United States, 78229